Science & Enterprise subscription

Follow us on Twitter

  • A new enterprise, spun off from Seattle Children’s Research Institute, is creating therapeutics for diseases from e… https://t.co/CvnMEFT0Cm
    about 7 hours ago
  • New post on Science and Enterprise: Start-Up Developing Engineered B-Cell Therapies https://t.co/vMgdwnIXdi #Science #Business
    about 7 hours ago
  • Global drug maker Roche Group is acquiring an experimental antiviral therapy for Covid-19 infections taken as a ora… https://t.co/e2d7m6HG1E
    about 10 hours ago
  • New post on Science and Enterprise: Roche Gains Covid-19 Oral Drug Candidate https://t.co/nh27g6uCwi #Science #Business
    about 10 hours ago
  • The day that America lost $100 billion because of an immigration visa ban https://t.co/OfEx6SFwxA via @BrookingsInst
    about 24 hours ago

Please share Science & Enterprise

Roche Gains Covid-19 Oral Drug Candidate

Pills and capsules

Global drug maker Roche Group is acquiring an experimental antiviral therapy for Covid-19 infections taken as a oral drug, rather than an infusion. . . . → Read More: Roche Gains Covid-19 Oral Drug Candidate

Software Designed to Model, Visualize Brain Circuits

NetPyNE GUI screen

An academic-industry team designed a web-based software tool to ease the computer modeling, simulation, and visualization of the brain’s nerve cell circuits. . . . → Read More: Software Designed to Model, Visualize Brain Circuits

Covid-19 Vaccine Challenge Trial Underway

Syrine ingloved hand

Researchers in the U.K. are beginning a human challenge trial that intentionally exposes volunteers to SARS-CoV-2 viruses to test candidate vaccines. . . . → Read More: Covid-19 Vaccine Challenge Trial Underway

Cancer Center, Biotech Partner on Off-the-Shelf T-Cells

T-cells and cancer cells

MD Anderson Cancer Center and Allogene Therapeutics Inc. agreed to jointly study the company’s cancer treatments derived from donated T-cells. . . . → Read More: Cancer Center, Biotech Partner on Off-the-Shelf T-Cells

Individual Cells Explored with Virtual Reality

vLume image

A new software package uses virtual reality to allow biologists and medical researchers to visualize and explore inside individual cells in three dimensions. . . . → Read More: Individual Cells Explored with Virtual Reality

Engineered Heart Tissue Mechanisms Probed

Heart and major blood vessels

A research institute is partnering with a company creating heart tissue patches from stem cells to better understand the details of how the patch works. . . . → Read More: Engineered Heart Tissue Mechanisms Probed

Biotech, Analytics Companies Partner on Drug Discovery

Population genetics

A biotechnology company and genomics data science enterprise agreed in a multi-year agreement to discover new therapies for up to 20 diseases. . . . → Read More: Biotech, Analytics Companies Partner on Drug Discovery

Group Advancing Electronic Spinal Cord Injury Therapies

Spine

A consortium of academic and industry labs is integrating electronic sensors and neural stimulation therapies into an early treatment protocol for spinal cord injuries. . . . → Read More: Group Advancing Electronic Spinal Cord Injury Therapies

Study Testing Wearables Data for Covid-19 Clues

Smart watch with PhysIQ app

A biomedical engineering lab and analytics company are testing the feasibility of algorithms to find early signs of Covid-19 symptoms from smart watch users. . . . → Read More: Study Testing Wearables Data for Covid-19 Clues

Dexcom, UVirginia Partner on Diabetes Technology

Artificial pancreas system

Dexcom Inc., a maker of glucose monitoring systems, and University of Virginia are collaborating on extending the company’s current technologies to cover more types of diabetes . . . → Read More: Dexcom, UVirginia Partner on Diabetes Technology